NCT04259047View on ClinicalTrials.gov

Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: a Randomized Clinical Trial

PHASE2CompletedINTERVENTIONAL

Enrollment

145

Participants

Timeline

Start Date

October 25, 2021

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions

Mild Cognitive ImpairmentDiabetes

Interventions

BEHAVIORAL

Diabetes Regulation for Eyesight and Memory

Participants randomized to DREAM will have 11 in-home visits over 2 years with a CHW, and 4 telehealth visits with a DM nurse educator.

BEHAVIORAL

Enhanced Usual Care

Participants in this group will have 11 in-home CHW visits over 24 months to control for attention. During these visits, the CHW will provide general diabetes education. There will be no telehealth visits.

Trial Locations (1)

19107

Thomas Jefferson University, Philadelphia

All Listed Sponsors

lead

Thomas Jefferson University

OTHER

NCT04259047 - Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: a Randomized Clinical Trial | Biotech Hunter | Biotech Hunter